Optiver Holding’s Greenwich LifeSciences GLSI Stock Holding History

Optiver Holding’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.31K	Hold	96	–	–	﹤0.01%	1791
2025 Q4	$2.02K	Hold	96	–	–	﹤0.01%	2016
2025 Q3	$955	Buy	+96	New	+$1.08K	﹤0.01%	2505

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Optiver Holding's GLSI Position: Q1 2026 in Review

Optiver Holding held its Greenwich LifeSciences (GLSI) position steady in Q1 2026 at 96 shares worth $2.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1791.

Optiver Holding first reported a position in GLSI in Q3 2025 and has held it in 3 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

Optiver Holding held 96 shares of Greenwich LifeSciences worth $2.31K as of Q1 2026.
Optiver Holding left its Greenwich LifeSciences share count unchanged in Q1 2026.
Greenwich LifeSciences made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1791 holding.
Optiver Holding first reported a position in Greenwich LifeSciences in Q3 2025 and has held it in 3 quarters since.
64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.